Using innovative molecular detection to advance the diagnosis and management of cancer
The Most Extensive Microarray Available For Pathogen Detection
PathoChip technology is a proprietary method of identifying specific microbial signatures associated with cancer. Pathochip can accurately detect pathogens that may cause or complicate a disease, impacting treatment, prognosis, and follow-up.
ExcaliVir, a molecular diagnostics company, was formed in 2012 by Dr. Erle Robertson and Dr. James Alwine, researchers from the University of Pennsylvania, Perelman School of Medicine to transform pathogen detection by combining next generation microarray and sequencing. Their passion for research on the relationship between the microbiome and human cancer has led to the development of a unique technology for rapid identification of all known infectious agents associated with human disease.